Item 1.01. Entry into a Material Definitive Agreement.
On
The Company previously granted SIIPL a license to manufacture and use the Drug
Substance, along with Adjuvant (supplied by the Company) and know-how of the
Company, to develop, manufacture and commercialize the Product in its licensed
territory under a supply and license agreement that was last amended and
restated as of
Pursuant to the Supply Agreement, SIIPL is solely responsible for obtaining and maintaining all necessary permits or other regulatory approvals to manufacture the Product. Unless otherwise terminated earlier, the Supply Agreement will expire on the later of three years from the effective date of the Supply Agreement or two years after the expiration or termination of the last firm purchase order under the Supply Agreement. Either party may terminate the Supply Agreement if the other party files a petition for bankruptcy or commits a material breach of the Supply Agreement that is not timely cured or is not curable. The Supply Agreement includes customary representations and warranties of the parties along with certain customary covenants, including confidentiality and indemnity provisions.
The foregoing description of the material terms of the Supply Agreement does not
purport to be complete and is qualified in its entirety by reference to the
Supply Agreement, which will be filed with the
© Edgar Online, source